5:36 PM
Nov 04, 2015
 |  BC Extra  |  Financial News

Cancer microbiome play Evelo raises $35M

Evelo Therapeutics Inc. raised $35 million in an initial financing from sole investor Flagship Ventures. The cancer microbiome company has operated within the firm's Flagship VentureLabs incubator for two years.


Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >